HUP0301868A2 - Gyógyászati készítmény, ami VIIa és XIII-as faktort tartalmaz - Google Patents
Gyógyászati készítmény, ami VIIa és XIII-as faktort tartalmazInfo
- Publication number
- HUP0301868A2 HUP0301868A2 HU0301868A HUP0301868A HUP0301868A2 HU P0301868 A2 HUP0301868 A2 HU P0301868A2 HU 0301868 A HU0301868 A HU 0301868A HU P0301868 A HUP0301868 A HU P0301868A HU P0301868 A2 HUP0301868 A2 HU P0301868A2
- Authority
- HU
- Hungary
- Prior art keywords
- factor
- pharmaceutical composition
- xiii
- viia
- factor viia
- Prior art date
Links
- 229940012414 factor viia Drugs 0.000 title abstract 3
- 229940012444 factor xiii Drugs 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 108010054265 Factor VIIa Proteins 0.000 abstract 2
- 108010071289 Factor XIII Proteins 0.000 abstract 2
- 208000032843 Hemorrhage Diseases 0.000 abstract 1
- 208000034158 bleeding Diseases 0.000 abstract 1
- 230000000740 bleeding effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Abstract
A találmány tárgya egy VIIa és egy XIII-as faktort tartalmazógyógyászati készítmény, valamint a VIIa és a XIII-as faktorkombinációjának használata olyan gyógyszer előállításában, amitvérzési epizódokban szenvedő betegek kezelésére, illetve ezeknek amegelőzésére lehet használni. A találmány tárgyát képezik továbbá azezeket a vegyületeket tartalmazó kitek is. Ó
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200000771 | 2000-05-10 | ||
DKPA200000778 | 2000-05-10 | ||
US20621200P | 2000-05-22 | 2000-05-22 | |
US20619400P | 2000-05-22 | 2000-05-22 | |
DKPA200000871 | 2000-06-06 | ||
US21285700P | 2000-06-20 | 2000-06-20 | |
PCT/DK2001/000322 WO2001085198A1 (en) | 2000-05-10 | 2001-05-10 | tHARMACEUTICAL COMPOSITION COMPRISING A FACTOR VIIA AND A FACTOR XIII |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0301868A2 true HUP0301868A2 (hu) | 2003-08-28 |
HUP0301868A3 HUP0301868A3 (en) | 2006-11-28 |
Family
ID=27222387
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0301868A HUP0301868A3 (en) | 2000-05-10 | 2001-05-10 | Pharmaceutical composition comprising a factor viia and a factor xiii |
Country Status (17)
Country | Link |
---|---|
US (3) | US20030092627A1 (hu) |
EP (3) | EP1282438B1 (hu) |
JP (2) | JP2004505016A (hu) |
CN (1) | CN1304049C (hu) |
AT (2) | ATE311198T1 (hu) |
AU (3) | AU5822801A (hu) |
BR (1) | BR0110659A (hu) |
CA (1) | CA2406583A1 (hu) |
CZ (1) | CZ20023667A3 (hu) |
DE (2) | DE60112429T2 (hu) |
DK (1) | DK1282438T3 (hu) |
ES (2) | ES2247106T3 (hu) |
HU (1) | HUP0301868A3 (hu) |
IL (1) | IL152554A0 (hu) |
NO (1) | NO20025355L (hu) |
PL (1) | PL365042A1 (hu) |
WO (2) | WO2001085199A1 (hu) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2386228A1 (en) * | 1999-10-04 | 2001-04-12 | Chiron Corporation | Stabilized liquid pharmaceutical compositions comprising tissue factor pathway inhibitor (tfpi) polypeptides |
US6905683B2 (en) | 2000-05-03 | 2005-06-14 | Novo Nordisk Healthcare A/G | Human coagulation factor VII variants |
US7015194B2 (en) | 2000-05-10 | 2006-03-21 | Novo Nordisk A/S | Pharmaceutical composition comprising factor VIIa and anti-TFPI |
PL204888B1 (pl) * | 2000-09-13 | 2010-02-26 | Novo Nordisk Healthcare Ag | Wariant polipeptydu czynnika VII, konstrukcja kwasu nukleinowego, rekombinowana komórka gospodarza, zwierzę transgeniczne, sposób wytwarzania wariantu polipeptydu czynnika VII, kompozycja farmaceutyczna i zastosowanie wariantu polipeptydu czynnika VII |
CN101486761A (zh) | 2000-09-13 | 2009-07-22 | 诺沃挪第克健康护理股份公司 | 人凝血因子vii变体 |
WO2002036155A1 (en) * | 2000-11-03 | 2002-05-10 | Zymogenetics, Inc. | Use of blood coagulation factor xiii for treating haemophilia a |
WO2002038162A1 (en) | 2000-11-09 | 2002-05-16 | The Scripps Research Institute | MODIFIED FACTOR VIIa |
DE60129599T2 (de) * | 2000-11-10 | 2008-04-17 | Zymogenetics, Inc., Seattle | Faktor xiii in kombination mit faktor ix zur behandlung von hämophilie b |
ATE386538T1 (de) * | 2001-02-05 | 2008-03-15 | Novo Nordisk Healthcare Ag | Kombinierte verwendung von faktor vii polypeptiden und faktor viii polypeptiden |
CA2438761A1 (en) * | 2001-02-21 | 2002-09-06 | Zymogenetics, Inc. | Method for treating von willebrand's disease |
CA2460023A1 (en) * | 2001-09-10 | 2003-03-20 | Zymogenetics, Inc. | Method for treating coumarin-induced hemorrhage |
US7052868B2 (en) | 2001-09-27 | 2006-05-30 | Novo Nordisk Healthcare A/G | Human coagulation factor VII polypeptides |
US6960657B2 (en) | 2001-11-02 | 2005-11-01 | Novo Nordisk Healthcare A/G | Human coagulation factor VII polypeptides |
EP1446148A1 (en) * | 2001-11-09 | 2004-08-18 | Novo Nordisk A/S | Pharmaceutical composition comprising a factor vii polypeptide and epsilon-aminocapronic acid |
US20030119723A1 (en) * | 2001-11-09 | 2003-06-26 | Rasmus Rojkjaer | Pharmaceutical composition comprising factor VII polypeptides and PAI-1 polypeptides |
EP1446147A1 (en) * | 2001-11-09 | 2004-08-18 | Novo Nordisk Health Care AG | Pharmaceutical composition comprising factor vii polypeptides and tranexamic acid |
US7291587B2 (en) | 2001-11-09 | 2007-11-06 | Novo Nordisk Healthcare A/G | Pharmaceutical composition comprising factor VII polypeptides and TAFI polypeptides |
IL162239A0 (en) * | 2001-12-21 | 2005-11-20 | Novo Nordisk Healthcare Ag | Liquid composition of factor vii polypeptides |
CN101675991A (zh) * | 2001-12-21 | 2010-03-24 | 诺和诺德医疗保健公司 | 因子ⅶ多肽的液体组合物 |
PT2283856T (pt) | 2002-06-21 | 2017-12-26 | Novo Nordisk Healthcare Ag | Composições sólidas estabilizadas de polipéptidos do fator viia |
US6911323B2 (en) | 2002-09-25 | 2005-06-28 | Novo Nordisk Healthcare A/G | Human coagulation factor VII polypeptides |
PT1599222E (pt) * | 2003-01-08 | 2009-06-12 | Novartis Vaccines & Diagnostic | Composições aquosas estabilizadas que contêm um inibidor da via do factor tecidular (tfpi) ou uma variante do inibidor da via do factor tecidular |
EP1641487B1 (en) | 2003-06-25 | 2012-02-29 | Novo Nordisk Health Care AG | Liquid composition of factor vii polypeptides |
BRPI0413518A (pt) | 2003-08-14 | 2006-10-10 | Novo Nordisk Healthcare Ag | composição farmacêutica lìquida aquosa, método para preparar e uso da mesma, método para tratar uma sìndrome responsiva ao fator vii, e, recipiente hermético |
ES2381110T3 (es) | 2003-09-09 | 2012-05-23 | Novo Nordisk Health Care Ag | Polipéptidos de factor VII de coagulación |
WO2005107795A1 (en) * | 2004-05-11 | 2005-11-17 | Novo Nordisk Health Care Ag | Use of factor viia for the treatment of burn traumas |
WO2005115442A1 (en) * | 2004-05-25 | 2005-12-08 | Novo Nordisk Health Care Ag | Use of coagulation factor xiii for treatment of post surgical bleedings |
JP2008510476A (ja) * | 2004-08-27 | 2008-04-10 | ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト | 生物学的材料からのxiii因子ポリペプチドの精製 |
BRPI0515163A (pt) * | 2004-09-10 | 2008-07-08 | Pharmaorigin Aps | métodos para tratar hemoptise ou sangramento traqueal, brÈnquico ou alveolar local |
US8461302B2 (en) | 2004-11-23 | 2013-06-11 | Zymogenetics, Inc. | Purification of recombinant human factor XIII |
US20090130086A1 (en) * | 2005-02-28 | 2009-05-21 | Novo Nordisk Health Care Ag | FXIII Variants with Improved Properties |
US20080161425A1 (en) * | 2005-07-29 | 2008-07-03 | Universiteit Van Maastricht | Regulation of Tissue Factor Activity by Protein S and Tissue Factor Pathway Inhibitor |
ES2399138T3 (es) | 2006-03-16 | 2013-03-26 | Stellaris Pharmaceuticals Aps | Tratamiento local con factor VII |
WO2008009634A2 (en) * | 2006-07-17 | 2008-01-24 | Novo Nordisk Health Care Ag | Factor viia analogues with increased activity for treating thrombocytopenia |
SI2147096T1 (sl) * | 2007-04-13 | 2015-07-31 | Catalyst Biosciences, Inc., | Modificirani polipeptidi faktorja VII in njihove uporabe |
TWI465247B (zh) | 2008-04-11 | 2014-12-21 | Catalyst Biosciences Inc | 經修飾的因子vii多肽和其用途 |
KR101897534B1 (ko) | 2008-04-21 | 2018-09-12 | 노보 노르디스크 헬스 케어 악티엔게젤샤프트 | 건조한 트랜스글루타미나제 조성물 |
EP2149603A1 (en) | 2008-07-28 | 2010-02-03 | DRK-Blutspendedienst Baden-Württemberg-Hessen gGmbH | Factor IX variants with clotting activity in absence of their cofactor and their use for treating bleeding disorders |
UA112050C2 (uk) * | 2008-08-04 | 2016-07-25 | БАЄР ХЕЛСКЕР ЛЛСі | Терапевтична композиція, що містить моноклональне антитіло проти інгібітора шляху тканинного фактора (tfpi) |
BR122021014783B1 (pt) * | 2008-12-19 | 2023-03-14 | Baxalta GmbH | Peptídeo que se liga a tfpi, uso do peptídeo, composição farmacêutica e método para purificação de tfpi |
AU2011227714B2 (en) | 2010-03-19 | 2014-09-04 | Takeda Pharmaceutical Company Limited | TFPI inhibitors and methods of use |
CA2807749C (en) | 2010-08-05 | 2023-02-28 | Council Of Scientific & Industrial Research | Protein fusion constructs possessing thrombolytic and anticoagulant properties |
KR102263685B1 (ko) | 2012-03-21 | 2021-06-11 | 다케다 야쿠힌 고교 가부시키가이샤 | Tfpi 저해제 및 사용 방법 |
EP2881463A1 (en) | 2013-12-09 | 2015-06-10 | DRK-Blutspendedienst Baden-Württemberg-Hessen gGmbH | Factor IX variants with clotting activity in absence of their cofactor and/or with increased F.IX clotting activity and their use for treating bleeding disorders |
JP6559188B2 (ja) * | 2017-07-06 | 2019-08-14 | バイエル・ヘルスケア・エルエルシーBayer HealthCare LLC | 組織因子経路インヒビター(tfpi)に対するモノクローナル抗体 |
JP2018038398A (ja) * | 2017-09-04 | 2018-03-15 | バイエル・ヘルスケア・エルエルシーBayer HealthCare LLC | 組織因子経路インヒビター(tfpi)に対するモノクローナル抗体 |
JP2018108089A (ja) * | 2018-02-19 | 2018-07-12 | バイエル・ヘルスケア・エルエルシーBayer HealthCare LLC | 組織因子経路インヒビター(tfpi)に対するモノクローナル抗体 |
CN112424593A (zh) | 2018-07-25 | 2021-02-26 | 索尼公司 | 凝血系统分析装置 |
JP6848016B2 (ja) * | 2019-07-16 | 2021-03-24 | バイエル・ヘルスケア・エルエルシーBayer HealthCare LLC | 組織因子経路インヒビター(tfpi)に対するモノクローナル抗体 |
WO2021030787A1 (en) | 2019-08-15 | 2021-02-18 | Catalyst Biosciences, Inc. | Modified factor vii polypeptides for subcutaneous administration and on-demand treatment |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4221780A (en) * | 1978-12-04 | 1980-09-09 | Cort Joseph H | Method for producing high potency factor VIII |
AU593042B2 (en) * | 1985-11-26 | 1990-02-01 | Novo Nordisk Health Care Ag | Compositions and methods for the treatment of bleeding disorders |
US5622988A (en) * | 1990-06-15 | 1997-04-22 | Novo Nordisk A/S | Use of a low molecular weight metabolite from fungus for reducing prolonged coagulation time |
DK261490D0 (da) * | 1990-10-31 | 1990-10-31 | Novo Nordisk As | New pharmaceutical compound |
CZ83194A3 (en) * | 1991-10-11 | 1994-11-16 | Novo Nordisk As | Haemostatic preparation for inducing blood precipitation on a bleeding wound |
CA2127107C (en) * | 1991-12-31 | 2007-06-19 | Bruce L. A. Carter | Methods and compositions for reducing blood loss |
AU4784693A (en) * | 1992-07-24 | 1994-02-14 | Oklahoma Medical Research Foundation | Blockade of protein c activation reduces microvascular surgical blood loss |
DE4429118C2 (de) * | 1994-08-17 | 1997-01-16 | Siemens Ag | Radarsensor |
EP0885020A1 (en) * | 1996-02-20 | 1998-12-23 | Cohesion Corporation | Tissue sealant compositions and methods of use thereof |
WO1998058661A1 (en) * | 1997-06-23 | 1998-12-30 | Novo Nordisk A/S | Use of fviia for the treatment of bleedings in patients with a normal blood clotting cascade and normal platelet function |
CA2318434A1 (en) * | 1997-12-23 | 1999-07-01 | Nuvas Llc | Thrombogenic polypeptide chimeras and conjugates having activity dependent upon association with tumor vascular endothelium |
CA2328493A1 (en) * | 1998-05-14 | 1999-11-18 | Battelle Memorial Institute | Transgenic plant-derived human blood coagulation factors |
EP1148427A1 (en) * | 2000-04-21 | 2001-10-24 | Koninklijke KPN N.V. | Method of and system for creating a button type bookmark in a web browser displaying a user-selected part of the corresponding data file |
US7015194B2 (en) * | 2000-05-10 | 2006-03-21 | Novo Nordisk A/S | Pharmaceutical composition comprising factor VIIa and anti-TFPI |
US6825323B2 (en) * | 2001-01-10 | 2004-11-30 | The United States Of America As Represented By The Secretary Of The Army | Compositions for treatment of hemorrhaging with activated factor VIIa in combination with fibrinogen and methods of using same |
ATE386538T1 (de) * | 2001-02-05 | 2008-03-15 | Novo Nordisk Healthcare Ag | Kombinierte verwendung von faktor vii polypeptiden und faktor viii polypeptiden |
US20030203845A1 (en) * | 2001-02-05 | 2003-10-30 | Knudsen Jens Bjerre | Combined use of factor VII polypeptides and factor IX polypeptides |
US20030119741A1 (en) * | 2001-11-09 | 2003-06-26 | Rasmus Rojkjaer | Pharmaceutical composition comprising factor VII polypeptides and aprotinin polypeptides |
US7419949B2 (en) * | 2001-07-16 | 2008-09-02 | Novo Noridsk Healthcare A/G | Single-dose administration of factor VIIa |
US20060025336A1 (en) * | 2001-07-16 | 2006-02-02 | Novo Nordisk A/S | Pharmaceutical compositions comprising combinations of factor VII polypeptides and aprotinin polypeptides |
US20030040480A1 (en) * | 2001-07-20 | 2003-02-27 | Rasmus Rojkjaer | Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptides |
JP2005526004A (ja) * | 2001-11-09 | 2005-09-02 | ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト | 第vii因子ポリペプチドおよびトラネキサム酸を含む薬学的組成物 |
EP1446148A1 (en) * | 2001-11-09 | 2004-08-18 | Novo Nordisk A/S | Pharmaceutical composition comprising a factor vii polypeptide and epsilon-aminocapronic acid |
US20030119723A1 (en) * | 2001-11-09 | 2003-06-26 | Rasmus Rojkjaer | Pharmaceutical composition comprising factor VII polypeptides and PAI-1 polypeptides |
US7078479B2 (en) * | 2001-11-09 | 2006-07-18 | Novo Nordisk Healthcare A/G | Pharmaceutical composition comprising factor VII polypeptides and alpha2-antiplasmin polypeptides |
US7291587B2 (en) * | 2001-11-09 | 2007-11-06 | Novo Nordisk Healthcare A/G | Pharmaceutical composition comprising factor VII polypeptides and TAFI polypeptides |
US20030124118A1 (en) * | 2001-11-27 | 2003-07-03 | Rasmus Rojkjaer | Pharmaceutical composition comprising factor VII polypeptides and protein S inhibitors |
US20030119743A1 (en) * | 2001-11-09 | 2003-06-26 | Rasmus Rojkjaer | Pharmaceutical composition comprising factor VII polypeptides and tissue plasminogen inhibitors |
EP1446150A1 (en) * | 2001-11-09 | 2004-08-18 | Novo Nordisk Health Care AG | Pharmaceutical composition comprising factor vii polypeptides and protein c inhibitors |
US7125846B2 (en) * | 2001-11-09 | 2006-10-24 | Novo Nordisk Healthcare A/G | Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptides |
-
2001
- 2001-05-10 AU AU5822801A patent/AU5822801A/xx active Pending
- 2001-05-10 DE DE60112429T patent/DE60112429T2/de not_active Expired - Lifetime
- 2001-05-10 ES ES01931458T patent/ES2247106T3/es not_active Expired - Lifetime
- 2001-05-10 DK DK01931458T patent/DK1282438T3/da active
- 2001-05-10 AT AT01931460T patent/ATE311198T1/de not_active IP Right Cessation
- 2001-05-10 AT AT01931458T patent/ATE300953T1/de not_active IP Right Cessation
- 2001-05-10 BR BR0110659-7A patent/BR0110659A/pt not_active IP Right Cessation
- 2001-05-10 CN CNB018093116A patent/CN1304049C/zh not_active Expired - Fee Related
- 2001-05-10 IL IL15255401A patent/IL152554A0/xx unknown
- 2001-05-10 CA CA002406583A patent/CA2406583A1/en not_active Abandoned
- 2001-05-10 EP EP01931458A patent/EP1282438B1/en not_active Expired - Lifetime
- 2001-05-10 PL PL01365042A patent/PL365042A1/xx not_active Application Discontinuation
- 2001-05-10 EP EP05007833A patent/EP1593389A1/en not_active Withdrawn
- 2001-05-10 DE DE60115422T patent/DE60115422T2/de not_active Expired - Fee Related
- 2001-05-10 AU AU2001258230A patent/AU2001258230A1/en not_active Abandoned
- 2001-05-10 WO PCT/DK2001/000324 patent/WO2001085199A1/en active IP Right Grant
- 2001-05-10 AU AU2001258228A patent/AU2001258228B2/en not_active Ceased
- 2001-05-10 HU HU0301868A patent/HUP0301868A3/hu unknown
- 2001-05-10 CZ CZ20023667A patent/CZ20023667A3/cs unknown
- 2001-05-10 JP JP2001581851A patent/JP2004505016A/ja not_active Withdrawn
- 2001-05-10 JP JP2001581852A patent/JP2003532684A/ja active Pending
- 2001-05-10 ES ES01931460T patent/ES2254414T3/es not_active Expired - Lifetime
- 2001-05-10 WO PCT/DK2001/000322 patent/WO2001085198A1/en active IP Right Grant
- 2001-05-10 EP EP01931460A patent/EP1282439B1/en not_active Expired - Lifetime
-
2002
- 2002-10-15 US US10/271,278 patent/US20030092627A1/en not_active Abandoned
- 2002-11-08 NO NO20025355A patent/NO20025355L/no not_active Application Discontinuation
-
2006
- 2006-03-28 US US11/391,065 patent/US20060199766A1/en not_active Abandoned
-
2007
- 2007-05-30 US US11/755,298 patent/US20070280920A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0301868A2 (hu) | Gyógyászati készítmény, ami VIIa és XIII-as faktort tartalmaz | |
HUP0401998A2 (hu) | PDE9 inhibitorok alkalmazása olyan gyógyszer előállítására, amellyel inzulin-rezisztencia szindróma és 2-es típusú diabétesz kezelhető | |
HUP0301452A2 (hu) | Fotokemoterápiás szert és mukoadhéziós szert tartalmazó gyógyszerkészítmény és alkalmazása | |
HUP0300426A2 (hu) | Antihipertenzív és anti-angiogén szerek terápiás kombinációja és ezeket tartalmazó gyógyszerkészítmények | |
EE200300033A (et) | Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon | |
HUP0203556A2 (hu) | Oxkarbazepint tartalmazó gyógyszerkészítmények és alkalmazásuk | |
HUP0303143A2 (hu) | A VII-es faktor és a IX-es faktor polipeptidek kombinált alkalmazása | |
IL154888A (en) | Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid | |
NO324227B1 (no) | Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer | |
HUP0202862A2 (hu) | A loteprednol és antihisztaminok új kombinációját tartalmazó gyógyszerkészítmény | |
HUP0303082A2 (hu) | Szubsztituált indolil-oxo-acetil-piperazinszármazékok, ezeket tartalmazó készítmények és vírusellenes alkalmazásuk | |
HUP0400782A2 (hu) | Antikolinergikumokon és PDE-IV inhibitorokon alapuló új gyógyszerkészítmények | |
ATE543491T1 (de) | Kombinationspräparat enthaltend ibuprofen und paracetamol | |
HUP9903496A2 (hu) | Xa-faktor elleni aktivitású vegyületet és vérlemezke-aggregációt antagonizáló vegyületet tartalmazó gyógyászati készítmény | |
HUP0400850A2 (hu) | Orálisan adagolható gyógyászati készítmények | |
ATE298324T1 (de) | Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel | |
ATE308328T1 (de) | Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen | |
ATE231852T1 (de) | Bicyclische aromatische verbindungen | |
CY1107231T1 (el) | Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης | |
ATE309817T1 (de) | Pharmazeutische zusammensetzung die trkaig2 enthält zur verwendung in der vorbeugung und/oder behandlung von krebs | |
DE60202590D1 (de) | 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen | |
HUP0001104A2 (hu) | Ibuprofent és domperidont tartalmazó készítmények migrén kezelésére | |
HUP0004461A2 (hu) | Apoliprotein B kiválasztást/mikroszomális trigliceridtranszfer-proteint gátló anyag alkalmazása gyógyászati készítmények előállítására és a fenti gyógyászati készítmények | |
HUP0204391A2 (en) | The use of mirtazapine for the preparation of pharmaceutical composition suitable for the treatment of sleep disorders | |
RS60604A (en) | Carboxamidine derivatives and their use in the treatment of vascular diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |